Itraconazole 치료로 호전을 보인 두경부 피부염 1예
A Case of Head and Neck Dermatitis Treated with Itraconazole
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Head and neck dermatitis is a variant of atopic dermatitis often seen in young adults. Pityrosporum is a normal skin commensal. Thus, its importance as a pathogen of atopic dermatitis was neglected in the past. It was found, however, that the treatment of head and neck dermatitis with an antifungal agent results in clinical improvement. At present, although the pathogenesis of atopic dermatitis has not yet been fully elucidated, Pityrosporum is considered one of the triggers of head and neck dermatitis. The case of an 18-year-old male who had a history of head and neck atopic dermatitis with erythematous xerotic patches accompanied by a yellowish colored crust and oozing on the facial area is reported herein. The lesion was treated with itraconazole monotherapy for four weeks, after which its condition improved.
Abstract
Head and neck dermatitis is a variant of atopic dermatitis often seen in young adults. Pityrosporum is a normal skin commensal. Thus, its importance as a pathogen of atopic dermatitis was neglected in the past. It was found, however, that the treatment of head and neck dermatitis with an antifungal agent results in clinical improvement. At present, although the pathogenesis of atopic dermatitis has not yet been fully elucidated, Pityrosporum is considered one of the triggers of head and neck dermatitis. The case of an 18-year-old male who had a history of head and neck atopic dermatitis with erythematous xerotic patches accompanied by a yellowish colored crust and oozing on the facial area is reported herein. The lesion was treated with itraconazole monotherapy for four weeks, after which its condition improved.
참고문헌 (17)
- Larsen FS, "Secular change in the occurance of atopic dermatitis", Acta Derm Venereol, 176, pp.7~12 (1992)
- Ogawa H, "A speculative view of atopic dermatitis: barrier dysfunction in pathogenesis", J Dermatol Sci, 5, pp.197~204 (1993)
- Svejgaard E, "Treatment of haed and neck dermatitis comparing itraconazole 200 mg and 400 mg daily for 1week with placebo", J Eur Acad Dermatol Venereol, 18, pp.445~449 (2004)
- Yarrow D., "A taxonomic study of yeast, 3rd ed", pp.882~885 (1984), Elsevior
- Waersted A, "Pityrosporum obbiculare: a pathogenic factor in atopic dermatitis of the face,scalp and neck?", Acta Derm Venereol Suppl (Stockh), 114, pp.146~148 (1985)
- Wessels MW, "IgE antibodies to Pityrosporum ovale in atopic dermatitis", Br J Dermatol, 125, pp.227~232 (1991)
- Kawaguchi H, "Malassezia and atopic dermatitis", Nippon Ishinkin Gakkai Zasshi, 44, pp.65~69 (2003)
- Tengvall LM, "Positive atopy patch test reaction to Pityrosporum orbiculare in atopic dermatitis patients", Clin Exp Aleergy, 30, pp.122~131 (2000)
- 이영, "두경부 아토피 피부염환자에서 Pityrosporum 특이 항체 검출과 임상양상과의 관계", 대피지, 43, pp.1482~1487 (2005)
- Erika JJ, "Atopic dermatitis of the face, scalp, and neck: Type 1 reaction to the yeast Pityrosporum ovale?", J Allergy Clin Immunol, 89, pp.44~51 (1992)
- Broberg A, "Topical antimycotic treatment of atopic dermatitis in the head", neck area, 1995, pp.75, 46~49
- Sehgal VN, "Antifungal agents: unapproved uses, dosages, or indication", Clin Dermatol, 20, pp.481~489 (2002)
- Ahn KJ, "Determination of minimum inhibitory concentrations of several azole antifungal for Malassezia furfur", Ann Dermatol, 8, pp.187~194 (1996)
- Naoko K, "Anti-mycotics suppress interleukin-4 and interleukin-5 productionin anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis", J Invest Dermatol, 117, pp.1635~1646 (2001)
- Ikezawa Z, "Clinical usefulness of oral itraconazole,and antimycotic drug, for refractory atopic dermatitis", Eur J Dermatol, 14, pp.400~406 (2004)
- Clemmensen, "Treatment of dermatitis of the head and neck with ketoconazole in patients with Type 1 sensetivity to Pityrosporum orbiculare", Semin Dermatol, 2, pp.26~29 (1983)
- 권순백, "청년기 지루피부염 환자의 아토피 증상 조사 및 혈중 IgE치와 호산구수 측정", 대피지, 37, pp.1269~1275 (1999)
